Diagnostics & imaging AI · Chest CT/X-ray AI
Riverain Technologies
Riverain Technologies builds FDA-cleared ClearRead AI for chest CT and X-ray to support detection of lung disease and more efficient thoracic reads. It is not an MRI acceleration product or multi-ology triage marketplace.
Strong fit
- Hospitals and imaging centers focused on finding lung nodules and chest disease on CT and X-ray
- Programs that will track detection results and reading time after ClearRead goes live
- Buyers comparing FDA-cleared chest AI rather than triage platforms that cover many specialties
Weak fit
- Sites whose main need is triage across specialties for stroke or pulmonary embolism
- Buyers without enough chest CT or X-ray volume to justify the module
- Teams that only need faster scans, which is Subtle's focus
Bottom line
Riverain Technologies is worth using for imaging programs focused on chest CT and X-ray detection rather than a broad triage platform. It suits radiologists who want FDA-cleared ClearRead tools in their usual viewer. Programs needing multi-finding CT triage should look at Aidoc or Avicenna.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Riverain Technologies builds FDA-cleared ClearRead AI for chest CT and X-ray. It helps find lung disease earlier and speeds up chest reads.
The company has focused on chest imaging for a long time. Its scope is narrower than Aidoc's multi-specialty platform and different from Subtle's focus on faster scans.
Results depend on radiologist trust, how false positives are handled, and whether reads stay in the usual viewer.
Setup is a clinical AI project tied into PACS, and pricing is custom.
Among the diagnostic imaging AI tools we review, Riverain scores alongside Studycast for specialty imaging AI.
Aidoc or Avicenna suit CT triage across many findings, and Subtle suits faster scans. Koios suits ultrasound decision support rather than chest CT and X-ray.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Aidoc | 7.9 | 7.5 |
| ScreenPoint Medical | 7.9 | 7.6 |
| Harrison.ai | 7.7 | 7.5 |
| Qure.ai | 7.4 | 7.1 |
| Optellum | 7.4 | 7.0 |
| Riverain Technologies | 7.3 | 6.9 |
| Subtle Medical | 7.2 | 6.8 |
| DeepTek | 7.1 | 6.8 |
| AZmed | 6.9 | 6.7 |
| Enlitic | 6.9 | 6.5 |
| Avicenna.AI | 6.9 | 6.6 |
| Ferrum Health | 6.8 | 6.5 |
| Koios Medical | 6.7 | 6.3 |
Pricing
| Item | Detail |
|---|---|
| Model | Software licenses for ClearRead CT and X-ray modules, priced by site and volume. |
| What usually drives cost | Number of sites, scan types (CT or X-ray), volume, and setup (on-site or cloud). |
| What to ask before you buy | Cost at your chest CT and X-ray volume, which FDA-cleared uses are covered, and PACS integration scope. |
| Published pricing | Riverain Technologies does not publish prices. Expect a custom quote. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Riverain Technologies to function | |
| A clinical owner in radiology, plus imaging IT | AI tools fail without both. |
| A written plan for connecting to PACS, RIS, and the EMR | Results that land where no one looks create a safety risk. |
| Agreement on which kinds of scans are covered | Trying to cover every kind of scan at once delays results. |
| A plan for who reviews alerts and AI-enhanced images | Lists no one owns get ignored. |
| Agreed times for changes that could interrupt clinical work | New screens that appear without warning during busy hours destroy trust. |
| What will maximize your value | |
| Measure turnaround, reopened reports, or the detection numbers agreed at kickoff | Accuracy in a demo does not prove it works day to day. |
| Start with one common type of scan | A small real win is worth more than a broad launch with nothing behind it. |
| Review false alarms with radiologists every week | Tools that raise too many false alarms get turned off. |
| Keep radiologists in the viewers they use now when possible | Extra reading lists drive radiologists away. |
| Check which of your scan types the FDA clearances cover | Paying for clearances that do not match your scans wastes money. |
| Deal-breakers | |
| There is no imaging IT or clinical owner. | |
| You will not do any connection work. | |
| You expect imaging AI to write clinical notes. | |
| No one will review alerts or AI-enhanced images. | |
| Your legal team blocks the cloud or vendor handling of patient data that you need. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Scope | 2-4 weeks. Agree on scan types, connections, and how success is measured. |
| 2 | Connect | 4-12 weeks. Connect to PACS, RIS, and the EMR, and test on real cases. |
| 3 | Pilot | 4-8 weeks. Run at one site or for one kind of scan. |
| 4 | Expand | Ongoing. Add sites and make adjustments. |
Leadership
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.